Viewing Study NCT06639269


Ignite Creation Date: 2025-12-24 @ 11:08 PM
Ignite Modification Date: 2026-01-04 @ 5:17 PM
Study NCT ID: NCT06639269
Status: COMPLETED
Last Update Posted: 2025-02-21
First Post: 2024-10-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Effect of Fertility Health Education Program on Fertility Health Knowledge and Healthy Life Awareness
Sponsor: Ankara University
Organization:

Study Overview

Official Title: Effect of Fertility Health Education Program Given to Young People on Fertility Health Knowledge and Healthy Life Awareness: Randomized Controlled Study
Status: COMPLETED
Status Verified Date: 2025-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study was planned to examine the effect of the fertility health education program given to young people on fertility health knowledge and healthy life awareness.

The study was planned to be conducted as a randomized controlled experimental study in the pre-test-post-test order.

The population of the research will consist of students studying at Gaziantep University Naci Topçuoğlu Vocational School in the 2024-2025 academic year. The research sample was calculated as a minimum of 64 people per group (experimental and control group) and 128 people in total. Considering the possible losses that may occur during the research process, a total of 146 students are planned to be accepted.

Data in the research; It will be collected through "Introductory Information Form", "Fertility Health Information Scale", "Healthy Life Awareness Scale" and "Training Program Satisfaction Survey".

In the research, the Fertility Health Education Program consisting of 3 sessions will be applied to the intervention group, and the control group will be informed about the research process and the data collection forms to be used. Data collection forms will be applied to students in both groups before and after the training.

In the analysis of the data; mean±standard deviation and median (minimum-maximum) will be used for quantitative variables as descriptors, and the number of patients (percentage) will be used for qualitative variables.

Student-t test, Mann-Whitney U test, One Way ANOVA test, Kruskal Wallis H test, Chi-square and Fisher exact tests will be used in the analysis, depending on the assumption of normal distribution. Risk factors affecting the qualitative dependent variable will be examined with Logistic Regression analysis. The statistical significance level will be taken as 0.05.
Detailed Description: The study is planned to be conducted in three stages: first stage (pre-intervention), second stage (intervention) and third stage (post-intervention). First Stage (Pre-Intervention): Students studying at the Vocational School where the study will be conducted will be informed about the study and invited to participate in the study. A list of students who meet the inclusion criteria and agree to participate in the study will be created. The gender and phone numbers of the students will be recorded while creating the list. The list will be sent to a statistician to determine the intervention and control groups using the randomization method. Students will be randomized into the intervention and control groups with similar gender distribution. Consent will be obtained from the participants included in the study through the Informed Consent Form.

Second Stage (Intervention): The "Fertility Health Education Program", which will be developed in line with literature information, will be applied to the intervention group. Both the pre-test and the first session of the training will be held on the same day. All participants will be asked to fill out the Introductory Information Form, Fertility Health Information Scale and Healthy Life Awareness Scale during the pre-test stage.

Third Phase (Post-Intervention): In this study, the post-test is planned to be administered 4 weeks after the last training. In order to complete the post-test, students in the intervention group will be contacted 4 weeks after the last training and the control group will be contacted 6 weeks after the pre-test and the Fertility Health Knowledge Scale and Healthy Life Awareness Scale will be completed.

In order to conduct the research, permission was obtained from Ankara University Ethics Committee with the decision numbered 06/04 and dated 03.04.2024, and in order to collect the research data, permission was obtained from Gaziantep University Naci Topçuoğlu Vocational School, where the research will be conducted, dated 02.09.2024 and numbered E-87841438-100-539736. Data collection forms will be distributed to the volunteers by the researcher, and the forms will be filled in by the volunteers. While filling out the forms, a distanced seating arrangement will be created so that the volunteers cannot see each other's answers. The data obtained from the research will be analyzed anonymously and the confidentiality of the data will be ensured. The research will be conducted in accordance with the Declaration of Helsinki. The researcher will inform the students who make up the sample that participation in the research is voluntary and that they can withdraw from the research at any time, and the purpose and method of the research will be explained. In addition to their verbal consent, students who agree to participate in the research will be asked to sign an Informed Consent Form. After the completion of the research, students in the control group who want to receive training and students who volunteer to participate in the study but cannot be in the intervention or control groups and want to receive training will be given a single session of fertility health training, an education booklet will be distributed, and a brochure will be sent to their phones.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: